Grants per year
Personal profile
Certifications and Licenses
| Hematology | |
| Medical Oncology |
Training Experience
| 2001 | Residency, Dalhousie University, Canada |
| 2004 | Fellowship, Univ. of Illinois Hospital |
Education/Academic qualification
MD, McGill University
… → 1998
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 10 Similar Profiles
Sarcoma
Medicine & Life Sciences
Head and Neck Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Protein-Tyrosine Kinases
Medicine & Life Sciences
Gastrointestinal Stromal Tumors
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2005 2023
Prot #ISA101b-HN-01-17: A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study of Cemiplimab Versus the Combination of Cemiplimab With ISA101b in the Treatment of Subjects With HPV16-Positive Platin-Resistant Oropharyngeal Cancer (OPC)
Syneos Health, Inc., ISA Therapeutics B.V.
4/22/19 → 4/22/22
Project: Research project
Prot #E7080-G000-604: An Open-Label, Multi-Center, Roll-Over Study to Assess Long Term Safety of Lenvatinib Monotherapy or Lenvatinib Combination Regimen or Comparator Treatment Arm to Cancer Patients in Eisai Sponsored Lenvatinib Trials
PPD Investigator Services, LLC, Eisai, Inc.
2/11/19 → 2/11/22
Project: Research project
Prot #BLU-285-1303: An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Syneos Health, Inc., Blueprint Medicines Corporation
9/20/18 → 9/20/21
Project: Research project
The Robert H. Lurie Comprehensive Cancer Center
Agulnik, M., Awatramani, R., Backman, V., Benson III, A. B., Carthew, R. W., Cella, D., Chakravarti, D., Chandel, N., Crispino, J. D., Cristofanilli, M., Eklund, E. A., Frankfurt, O., Gordon, L. I., Green, K. J., Hahn, E. A., Horbinski, C. M., Horvath, C. M., Hussain, M., James, C. D., Kelleher, N. L., Khan, S. A., LaBonne, C., Larson, A. C., Matei, D. E., Meade, T. J., Mondragon, A., Mrksich, M., Munshi, H. G., Murphy, A. B., Penedo, F. J., Perlman, H. R., Peter, M. E., Platanias, L. C., Rademaker, A. W., Rappoport, J. Z., Rosenzweig, A. C., Scheidt, K. A., Simon, M. A., Sosman, J. A., Spring, B., Wei, J., Weiss, E. L. & Woloschak, G. E.
8/10/18 → 7/31/23
Project: Research project
Neoplasms
Medicine
Research
Population
Neoplasms
Medicine
N-acetoacetyl-N-deacetylcolchicine
Research
Population
Research Output 2001 2019
Piloting a financial counseling intervention for patients with cancer receiving chemotherapy
Kircher, S. M., Yarber, J., Rutsohn, J., Guevara, Y., Lyleroehr, M., Jackson, H. A., Walradt, J., Desai, B., Mulcahy, M. F., Kalyan, A., Benson, A. B., Agulnik, M., Mohindra, N. A., DeSouza, J. & Garcia, S. F., Mar 1 2019, In : Journal of oncology practice. 15, 3, p. E202–E210Research output: Contribution to journal › Article
Counseling
Drug Therapy
Neoplasms
Costs and Cost Analysis
Workflow
22
Citations
(Scopus)
Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)
Ma, B. B. Y., Lim, W. T., Goh, B. C., Hui, E. P., Lo, K. W., Pettinger, A., Foster, N. R., Riess, J. W., Agulnik, M., Chang, A. Y. C., Chopra, A., Kish, J. A., Chung, C. H., Adkins, D. R., Cullen, K. J., Gitlitz, B. J., Lim, D. W., To, K. F., Chan, K. C. A., Lo, Y. M. D. & 5 others, Jan 1 2018, In : Journal of Clinical Oncology. 36, 14, p. 1412-1418 7 p.Research output: Contribution to journal › Article
Multicenter Studies
Survival Rate
Ligands
Disease-Free Survival
Biomarkers
7
Citations
(Scopus)
Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment
Rosenberg, A. & Agulnik, M., Apr 1 2018, In : Current treatment options in oncology. 19, 4, 19.Research output: Contribution to journal › Comment/debate
Epithelioid Hemangioendothelioma
Sarcoma
Immunotherapy
Clinical Trials
Therapeutics
1
Citation
(Scopus)
Growing Role of Regorafenib in the Treatment of Patients with Sarcoma
Agulnik, M. & Attia, S., Jun 21 2018, (Accepted/In press) In : Targeted Oncology. p. 1-6 6 p.Research output: Contribution to journal › Article
Sarcoma
Gastrointestinal Stromal Tumors
Leiomyosarcoma
Therapeutics
Synovial Sarcoma
Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: A case report and review
Chae, Y. K., Chiec, L., Adney, S. K., Waitzman, J., Costa, R., Carneiro, B., Matsangou, M., Agulnik, M., Kopp, P. A. & Giles, F., Jun 15 2018, In : Oncotarget. 9, 46, p. 28281-28289 9 p.Research output: Contribution to journal › Article
Posterior Leukoencephalopathy Syndrome
Takotsubo Cardiomyopathy
Thyroid Neoplasms
Protein-Tyrosine Kinases
Pharmaceutical Preparations